Characterization of Escherichia coli O157:H7 isolates causing haemolytic uraemic syndrome in France

Journal of Medical Microbiology

Volumn 54, Issue 1, 2005, Pages 71-75

  Bidet, Philippe ^a   Mariani Kurkdjian, Patricia ^a   Grimont, Francine ^b   Brahimi, Naïma ^a   Courroux, Céline ^a   Grimont, Patrick ^b   Bingen, Edouard ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLONE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; EAE GENE; ESCHERICHIA COLI; FRANCE; HEMOLYTIC UREMIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; STX2 GENE;

ADHESINS, BACTERIAL; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FECES; FRANCE; GENES, BACTERIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SHIGA-LIKE TOXIN II;

EID: 12744261235     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45841-0     Document Type: Article

References (41)

1. Allison, L. J., Carter, P. E. & Thomson-Carter, F. M. (2000). Characterization of a recurrent clonal type of Escherichia coli O157:H7 causing major outbreaks of infection in Scotland. J Clin Microbiol 38, 1632-1635.
2. Armstrong, G. L., Hollingsworth, J. & Morris, J. G., Jr (1996). Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev 18, 29-51.
3. Barrett, T. J., Lior, H., Green, J. H., Khakhria, R., Wells, J. G., Bell, B. P., Greene, K. D., Lewis, J. & Griffin, P. M. (1994). Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol 32, 3013-3017.
4. Bastian, S. N., Carle, I. & Grimont, F. (1998). Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli. Res Microbiol 149, 457-472.
5. Basualdo, W. & Arbo, A. (2003). Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr Infect Dis J 22, 374-377.
6. Beaudry, M., Zhu, C., Fairbrother, J. M. & Harel, J. (1996). Genotypic and phenotypic characterization of Escherichia coli isolates from dogs manifesting attaching and effacing lesions. J Clin Microbiol 34, 144-148.
7. Bender, J. B., Hedberg, C. W., Besser, J. M., Boxrud, D. J., MacDonald, K. L. & Osterholm, M. T. (1997). Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular sub-typing. N Engl J Med 337, 388-394.
8. Bingen, E., Picard, B., Brahimi, N., Mathy, S., Desjardins, P., Elion, J. & Denamur, E. (1998). Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 177, 642-650.
9. Bohm, H. & Karch, H. (1992). DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis. J Clin Microbiol 30, 2169-2172.
10. Clermont, O., Bonacorsi, S. & Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66, 4555-4558.
11. Davis, M. A., Hancock, D. D., Besser, T. E. & Call, D. R. (2003). Evaluation of pulsed-field gel electrophoresis as a tool for determining the degree of genetic relatedness between strains of Escherichia coli O157:H7. J Clin Microbiol 41, 1843-1849.
12. Feng, P., Lampel, K. A., Karch, H. & Whittam, T. S. (1998). Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis 177, 1750-1753.
13. Fukushima, H., Hashizume, T., Morita, Y. & 7 other authors (1999). Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int 41, 213-217.
14. Giammanco, G. M., Pignato, S., Grimont, F., Grimont, P. A., Caprioli, A., Morabito, S. & Giammanco, G. (2002). Characterization of Shiga toxin-producing Escherichia coli O157:H7 isolated in Italy and in France. J Clin Microbiol 40, 4619-4624.
15. Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13, 60-98.
16. Guerrant, R. L., Van Gilder, T., Steiner, T. S. & 14 other authors (2001). Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32, 331-351.
17. Hiramatsu, K., Murakami, J., Kishi, K., Hirata, N., Yamasaki, T., Kadota, J., Shibata, T. & Nasu, M. (2003). Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. Int J Antimicrob Agents 21, 471-477.
18. Izumiya, H., Terajima, J., Wada, A., Inagaki, Y., Itoh, K. I., Tamura, K. & Watanabe, H. (1997). Molecular typing of enterohemorrhagic Escherichia coli O157:H7 isolates in Japan by using pulsed-field gel electrophoresis. J Clin Microbiol 35, 1675-1680.
19. Johnson, J. R., van der Schee, C., Kuskowski, M. A., Goessens, W. & van Belkum, A. (2002). Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis 186, 1852-1856.
20. Karmali, M. A. (1989). Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2, 15-38.
21. Karmali, M. A., Arbus, G. S., Petric, M., Patrick, M. L., Roscoe, M., Shaw, J. & Lior, H. (1988). Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse. Lancet 1, 526.
22. Keene, W. E., Hedberg, K., Harriott, D. E., Hancock, D. D., McKay, R. W., Barrett, T. J. & Fleming, D. W. (1997). A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk. J Infect Dis 176, 815-818.
23. Khan, W. A., Seas, C., Dhar, U., Salam, M. A. & Bennish, M. L. (1997). Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med 126, 697-703.
24. Kudva, I. T., Evans, P. S., Perna, N. T., Barrett, T. J., Ausubel, F. M., Blattner, F. R. & Calderwood, S. B. (2002). Strains of Escherichia coli O157:H7 differ primarily by insertions or deletions, not single-nucleotide polymorphisms. J Bacteriol 184, 1873-1879.
25. Liesegang, A., Sachse, U., Prager, R. & 9 other authors (2000). Clonal diversity of Shiga toxin-producing Escherichia coli O157:H7/H- in Germany - a ten-year study. Int J Med Microbiol 290, 269-278.
26. Mariani-Kurkdjian, P., Cave, H., Elion, J., Loirat, C. & Bingen, E. (1997). Direct detection of verotoxin genes in stool samples by polymerase chain reaction in hemolytic uremic syndrome patients in France. Clin Microbiol Infect 3, 117-119.
27. NCCLS (1997). Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th edn. Approved Standard M2-A6. Wayne, PA: National Committee for Clinical Laboratory Standards.
28. Noller, A. C., McEllistrem, M. C., Stine, O. C., Morris, J. G., Jr, Boxrud, D. J., Dixon, B. & Harrison, L. H. (2003). Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J Clin Microbiol 41, 675-679.
29. Perna, N. T., Plunkett, G., III, Burland, V. & 25 other authors (2001). Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409, 529-533.
30. Pierard, D., Muyldermans, G., Moriau, L., Stevens, D. & Lauwers, S. (1998). Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 36, 3317-3322.
31. Preston, M. A., Johnson, W., Khakhria, R. & Borczyk, A. (2000). Epidemiologic subtyping of Escherichia coli serogroup O157 strains isolated in Ontario by phage typing and pulsed-field gel electrophoresis. J Clin Microbiol 38, 2366-2368.
32. Pupo, G. M., Karaolis, D. K., Lan, R. & Reeves, P. R. (1997). Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect Immun 65, 2685-2692.
33. Riley, L. W., Remis, R. S., Helgerson, S. D. & 9 other authors (1983). Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308, 681-685.
34. Rolland, K., Lambert-Zechovsky, N., Picard, B. & Denamur, E. (1998). Shigella and enteroinvasive Escherichia coli strains are derived from distinct ancestral strains of E. coli. Microbiology 144, 2667-2672.
35. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
36. Tesh, V. L. & O'Brien, A. D. (1991). The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol 5, 1817-1822.
37. Watanabe, H., Terajima, J., Izumiya, H., Wada, A. & Tamura, K. (1999). Molecular analysis of enterohemorrhagic Escherichia coli isolates in Japan and its application to epidemiological investigation. Pediatr Int 41, 202-208.
38. Whittam, T. S., Wachsmuth, I. K. & Wilson, R. A. (1988). Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 157, 1124-1133.
39. Whittam, T. S., Wolfe, M. L., Wachsmuth, I. K., Orskov, F., Orskov, I. & Wilson, R. A. (1993). Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun 61, 1619-1629.
40. Willshaw, G. A., Smith, H. R., Cheasty, T., Wall, P. G. & Rowe, B. (1997). Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg Infect Dis 3, 561-565.
41. Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L. & Tarr, P. I. (2000). The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342, 1930-1936.